Table 1.
Patients' demographic and clinical characteristics.
| Variable | Value |
|---|---|
| N | 50 |
| Gender [male n (%)] | 29 (58) |
| Age (years) | 58.4 ± 9.9 |
| BMI (kg/m²) | 30.8 ± 5.7 |
| Systolic blood pressure (mm Hg) | 128.3 ± 15.5 |
| Diastolic blood pressure (mm Hg) | 74.9 ± 10.2 |
| Fasting glucose (mmol/L) | 7.7 ± 2.2 |
| Total cholesterol (mmol/L) | 4.7 ± 0.9 |
| Triglycerides (mmol/L)∗ | 1.6 (1.2–2.2) |
| HDL-C (mmol/L) | 1.2 ± 0.2 |
| LDL-C (mmol/L) | 2.8 ± 0.9 |
| Fasting glucose (mmol/L) | 7.7 ± 2.2 |
| HbA1c (mmol/mol) | 54.3 ± 12.6 |
| Duration of diabetes (years)∗ | 5.5 (2.0–9.25) |
| Presence of hypertension | 31 (62) |
| Smokers | 21 (42) |
| Treatment with sulphonylureas | 26 (52) |
| Treatment with metformin | 47 (94) |
| Treatment with meglitinides | 1 (2) |
| Treatment with thiazolidinediones | 8 (16) |
| Treatment with sitagliptin | 10 (20) |
(Data are presented as mean (±SD) or as n (%).
∗Median value (interquartile range).
BMI: body mass index, HDL-C: high density lipoprotein cholesterol, and LDL-C: low density lipoprotein cholesterol.
Hypertension was defined as systolic blood pressure >140 mm Hg or diastolic blood pressure >90 mm Hg or the use of antihypertensive medication.